Brain Na+, K+-ATPase activity in aging and disease

International Journal of Biomedical Science

Volumn 10, Issue 2, 2014, Pages 85-102

  Arnaiz, Georgina Rodríguez de Lores ^a   Ordieres, María Graciela López ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM);

AGING; ALZHEIMER DISEASE; BLOOD PRESSURE REGULATION; BRAIN CANCER; BRAIN INJURY; BRAIN ISCHEMIA; DEPRESSION; DIABETES MELLITUS; ENZYME ACTIVITY; EPILEPSY; HUMAN; LEARNING DISORDER; MANIA; MEMORY DISORDER; MENTAL STRESS; MOOD DISORDER; NERVE CELL EXCITABILITY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84903552010     PISSN: 15509702     EISSN: 15552810     Source Type: Journal    
DOI: None     Document Type: Review

References (175)

1. Skou J. The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim. Biophys. Acta. 1957; 23: 394-401.
2. Scheiner-Bobis G. The sodium pump. Its molecular properties and mechanics of ion transport. Eur. J. Biochem. 2002; 269: 2424-2433.
3. Albers RW, Siegel GJ. Membrane transport. In: Brady ST, Siegel GJ, Albers RW, Price D (Eds.). Basic Neurochemistry: Principles of Molecular, Cellular and Medical Neurobiology, 8th edn. Massachusetts, USA: Elsevier Academic Press. 2012; p41-62.
4. De Robertis E. The synaptosome. Two decades of cell fractionation of the brain. Intern. Brain Res. Org. Monogr. Ser. 1983; 10: 1-10.
5. Rodríguez de Lores Arnaiz G, Alberici M, De Robertis E. Ultrastructural and enzymic studies of cholinergic and non-cholinergic synaptic membranes isolated from brain cortex. J. Neurochem. 1967; 14: 215-225.
6. Mains RE, Eiper BA. Peptides. In: Brady ST, Siegel GJ, Albers RW, Price D (Eds.). Basic Neurochemistry: Principles of Molecular, Cellular and Medical Neurobiology, 8th edn. Massachusetts, USA: Elsevier Academic Press. 2012; p390-419.
7. Lingrel JB. The Physiological Significance of the Cardiotonic Steroid/Ouabain-Binding site of the Na, K-ATPase. Ann. Rev. Physiol. 2010; 72: 395-412.
8. Bagrov AY, Shapiro JI, Fedorova OV. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol. Rev. 2009; 61: 9-38.
9. Keenan SM, DeLisle RK, Welsh WJ, Paula S, Ball WJ Jr. Elucidation of the Na+, K+-ATPase digitalis binding site. J. Mol. Graph. Model. 2005; 23: 465-475.
10. DiPolo R, Beaugé L. Regulation of Na-Ca exchange. An overview. Ann. N. Y. Acad. Sci. 1991; 639: 100-111.
11. Plattner F, Bibb JA. Serine and Threonine Phosphorylation. In: Brady ST, Siegel GJ, Albers RW, Price D (Eds.). Basic Neurochemistry: Principles of Molecular, Cellular and Medical Neurobiology, 8th edn. Massachusetts, USA: Elsevier Academic Press. 2012; p467-492.
12. Bertorello AM, Aperia A, Walaas SI, Nairn AC, et al. Phosphorylation of the catalytic subunit of Na+, K+-ATPase inhibits the activity of the enzyme. Proc. Natl. Acad. Sci. USA. 1991; 88: 11359-11362.
13. Hermenegildo C, Felipo V, Miñana MD, Grisolía S. Inhibition of protein kinase C restores Na+, K+-ATPase activity in sciatic nerve of diabetic mice. J. Neurochem. 1992; 58: 1246-1249.
14. Hermenegildo C, Felipo V, Miñana MD, Romero FJ, et al. Sustained recovery of Na(+)-K(+)-ATPase activity in the sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC. Diabetes. 1993; 42: 257-262.
15. Yakel JL. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol. Sci. 1997; 18: 124-134.
16. Rusnak F, Mertz P. Calcineurin: form and function. Physiol. Rev. 2000; 80: 1483-1521.
17. Li D, Aperia A, Celsi G, da Cruz e Silva EF, et al. Protein phosphatase-1 in the kidney: evidence for a role in the regulation of medullary Na(+)-K(+)-ATPase. Am. J. Physiol. 1995; 269: F673-F680.
18. Shamraj OI, Lingrel JB. A putative fourth Na+, K(+)-ATPase alphasubunit gene is expressed in testis. Proc. Natl. Acad. Sci. USA. 1994; 91: 12952-12956.
19. Antolovic R, Bruller H J, Bunk S, Linder D, Schoner W. Epitope mapping by amino-acid-sequence-specific antibodies reveals that both ends of the alpha subunit of Na+/K(+)-ATPase are located on the cytoplasmic side of the membrane. Eur. J. Biochem. 1991; 199: 195-202.
20. Sweadner KJ. Isozymes of Na+, K+-ATPase. Biochim. Biophys. Acta. 1989; 988: 185-220.
21. Berrebi-Bertrand I, Maixent JM, Christe G, Leleièvre LG. Two active Na+/K+-ATPases of high affinity for ouabain in adult rat brain membranes. Biochim. Biophys. Acta. 1990; 1021: 148-156.
22. McGrail KM, Phillips JM, Sweadner KJ. Immunofluorescent localization of three Na, K-ATPase isozymes in the rat central nervous system: both neurons and glia express more than one Na, K-ATPase. J. Neurosci. 1991; 11: 381-391.
23. Cholet N, Pellerin L, Magistretti PJ, Hamel E. Similar perisynaptic glial localization for the Na+, K+-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat somatosensory cortex. Cerebr. Cortex. 2002; 12: 515-525.
24. Moseley AE, Lieske SP, Wetzel RK, James, PF, He S, et al. The Na, KATPase alpha 2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice. J. Biol. Chem. 2003; 278: 5317-5324.
25. Rodríguez de Lores Arnaiz G. Neuronal Na/K-ATPase and its regulation by catecholamines. Intern. Brain Res. Org. Monogr. Ser. 1983; 10: 147-158.
26. Rodríguez de Lores Arnaiz G. In search of synaptosomal Na+, K+-ATPase regulators. Molec. Neurobiol. 1992; 6: 359-375.
27. Rodríguez de Lores Arnaiz G. How many endobains are there? Neurochem. Res. 2000; 25; 1421-1430.
28. Kometiani Z, Jariashvili T. The Na/K-ATPase regulation by neurotransmitters in ontogeny. Arch. Physiol. Biochem. 2000; 108: 360-370.
29. Teixeira VL, Katz AI, Pedemonte CH, Bertorello AM. Isoform-specific regulation of Na+, K+-ATPase endocytosis and recruitment to the plasma membrane. Ann. N. Y. Acad. Sci. 2003; 986: 587-594.
30. Eakle KA, Kabalin MA, Wang SG, Farley RA. The influence of beta subunit structure on the stability of Na+/K+-ATPase complexes and interaction with K+. J. Biol. Chem. 1994; 269: 6550-6557.
31. Chow DC, Forte JG. Functional significance of the beta-subunit for heterodimeric P-type ATPases. J. Exp. Biol. 1995; 198: 1-17.
32. Jaisser F, Horisberger JD, Rossier BC. The beta subunit modulates potassium activation of the Na-K pump. Ann. N. Y. Acad. Sci. 1992; 671: 113-119.
33. Lutsenko S, Kaplan JH. An essential role for the extracellular domain of the Na, K-ATPase beta-subunit in cation occlusion. Biochemistry. 1993; 32: 6737-6743.
34. Beguin P, Wang X, Firsov D, Puoti A, Claeys D, et al. The gamma subunit is a specific component of the Na, K-ATPase and modulates its transport function. EMBO J. 1997; 16: 4250-4260.
35. Therien AG, Blostein R. Mechanisms of sodium pump regulation. Am. J. Physiol. Cell Physiol. 2000; 279: C541-C566.
36. Geering K, Beguin P, Garty H, Karlish S, Fuzesi M, et al. FXYD proteins: new tissue-and isoform-specific regulators of Na, K-ATPase. Ann. N. Y. Acad. Sci. 2003; 986: 388-394.
37. Sweadner KJ, Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics. 2000; 68: 41-56.
38. Cornelius F, Mahmmoud Y. Functional modulation of the sodium pump: the regulatory proteins "Fixit". News Physiol. Sci. 2003; 18: 119-124.
39. Morton MJ, Farr GA, Hull M, Capendeguy O, Horisberger JD, et al. Association with {beta}-COP regulates the trafficking of the newly synthesized Na, K-ATPase. J. Biol. Chem. 2010; 285: 33737-33746.
40. Haas M, Askari A, Xie Z. Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J. Biol. Chem. 2000; 275: 27832-27837.
41. Xie Z. Molecular mechanisms of Na/K-ATPase-mediated signal transduction. Ann. N. Y. Acad. Sci. 2003; 986: 497-503.
42. Xie Z, Askari A. Na(+)/K(+)-ATPase as a signal transducer. Eur. J. Biochem. 2002; 269: 2434-2439.
43. Xie Z, Cai T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol. Interv. 2003; 3: 157-168.
44. Wang H, Haas M, Liang M, Cai T, Tian J, et al. Ouabain assembles signaling cascades through the caveolar Na+/K+-ATPase. J. Biol. Chem. 2004; 279: 17250-17259.
45. Hansen, O. 2003. No evidence for a role in signal-transduction of Na+/K+-ATPase interaction with putative endogenous ouabain. Eur. J. Biochem. 270: 1916-1919.
46. Liu J, Kesiry R, Periyasamy SM, Malhotra D, Xie Z, et al. Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK 1 cells by a clathrin-dependent mechanism. Kidney Int. 2004; 66: 227-241.
47. Lai F, Madan N, Ye Q, Duan Q, Li Z, et al. Identification of a mutant α1 Na/K-ATPase that pumps but is defective in signal transduction. J. Biol. Chem. 2013; 288: 13295-13304.
48. Li Z, Xie Z. The Na/K-ATPase/Src complex and cardiotonic steroidactivated protein kinase cascades. Pflugers Arch. 2009; 457: 635-644.
49. Kraemer DM, Strizek B, Meyer HE, Marcus K, Drenckhahn D. Kidney Na+, K+-ATPase is associated with moesin. Eur. J. Cell. Biol. 2003; 82: 87-92.
50. Kim M, Jung J, Park CS, Lee K. Identification of the cofilin-binding sites in the large cytoplasmic domain of Na, K-ATPase. Biochimie. 2002; 84: 1021-1029.
51. Kimura T, Allen PB, Nairn AC, Caplan MJ. Arrestins and spinophilin competitively regulate Na+, K+-ATPase trafficking through association with a large cytoplasmic loop of the Na+, K+-ATPase. Mol. Biol. Cell. 2007; 18: 4508-4518.
52. Yudowski GA, Efendiev R, Pedemonte CH, Katz AI, Berggren PO, et al. Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking. Proc. Natl. Acad. Sci. USA. 2000; 97: 6556-6561.
53. Cai T, Wang H, Chen Y, Liu L, Gunning WT, et al. Regulation of caveolin-1 membrane trafficking by the Na/K-ATPase. J. Cell. Biol. 2008; 182: 1153-1169.
54. Rose EM, Koo JC, Antflick JE, Ahmed SM, Angers S, et al. Glutamate transporter coupling to Na, K-ATPase. J. Neurosci. 2009; 29: 8143-8155.
55. Illarionova NB, Gunnarson E, Li Y, Brismar H, Bondar A, et al. Functional and molecular interactions between aquaporins and Na, KATPase. Neuroscience. 2010; 168: 915-925.
56. Barwe SP, Anilkumar G, Moon SY, Zheng Y, Whitelegge JP, et al. Novel role for Na, K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol. Biol. Cell. 2005; 16: 1082-1094.
57. Rajasekaran SA, Rajasekaran AK. Na, KATPase and epithelial tight junctions. Front. Biosci. (Landmark Ed.) 2009; 14: 2130-2148.
58. Cai H, Wu L, Qu W, Malhotra D, Xie Z. et al. Regulation of apical NHE3 trafficking by ouabain-induced activation of the basolateral Na+-K+-ATPase receptor comple. Am. J. Physiol. Cell. Physiol. 2008; 294: C555-563.
59. a. Desfrere L, Karlsson M, Hiyoshi H, Malmerjö S; Nanou E, et al. Na, K-ATPase signal transduction triggers CREB activation and dendritic growth. Proc. Natl. Acad. Sci. USA. 2009; 106: 2212-2217.
60. Johar K, Priya A, Dhar S, Liu Q, Wong-Riley MT. Neuron-specific specificity protein 4 bigenomically regulates the transcription of all mitochondria-and nucleus-encoded cytochrome c oxidase subunit genes in neurons. J. Neurochem. 2013; 127: 496-508.
61. Johar K, Priya A, Wong-Riley MT. Regulation of Na(+)/K(+)-ATPase by neuronspecific transcription factor Sp4: implication in the tight coupling of energy production, neuronal activity and energy consumption in neurons. Eur. J. Neurosci. 2014; 39: 566-578.
62. Bertoni JM, Siegel GJ. Development of (Na+-K+)-ATPase in rat cerebrum: correlation with Na+-dependent phosphorylation and K+-paranitrophenylphosphatase. J. Neurochem. 1978; 31: 1501-1511.
63. Schmitt CA, MacDonough AA. Developmental and thyroid hormone regulation of two molecular forms of Na+, K+-ATPase in brain. J. Biol. Chem. 1986; 261: 10439-10444.
64. Valcana T, Timiras PS. Effect of hypothyroidism on ionic metabolism and Na-K activated ATP phosphohydrolase activity in the developing rat brain. J. Neurochem. 1969; 16: 935-943.
65. Schmitt CA, MacDonough AA. Thyroid hormone regulates and isoforms of Na+, K+-ATPase during development in neonatal rat brain J. Biol. Chem. 1988; 263: 17643-17649.
66. Benzi G, Gorini A, Arnaboldi R, Ghigini B, Villa RF. Age-related alterations by chronic intermittent hypoxia on cerebral synaptosomal ATPase activities. J. Neural Transm Suppl. 1994; 44: 159-171.
67. Chauhan NB, Siegel GJ. In situ analysis of Na, K-ATPase alpha1-and alpha3-isoform mRNAs in aging rat hippocampus. J. Neurochem. 1996; 66: 1742-1751.
68. Chauhan N, Siegel G. Differential expression of Na, K-ATPase alphaisoform mRNAs in aging rat cerebellum. J. Neurosci. Res. 1997a; 47: 287-299.
69. Chauhan NB, Siegel GJ. Na, K-ATPase: increases in alpha1-messenger RNA and decreases in alpha3-messenger RNA levels in aging rat cerebral cortex. Neuroscience. 1997b; 78: 7-11.
70. Biser PS, Thayne KA, Kong JQ, Fleming WW, Taylor DA. Quantification of the alpha(3) subunit of the Na(+)/K(+)-ATPase in developing rat cerebellum. Brain Res. Dev. Brain Res. 2000; 123: 165-172.
71. Kocak H, Oner P, Oztaş B. Comparison of the activities of the Na(+), K(+)-ATPase in brains of rats at different ages. Gerontology. 2002; 48: 279-281.
72. Cohadon F, Desbordes P. Brain water and aging. Gerontology. 1986; 32 Suppl. 1: 46-49.
73. Tanaka Y, Ando S. Synaptic aging as revealed by changes in membrane potential and decreased activity of Na(+), K(+)-ATPase. Brain Res. 1990; 506: 46-52.
74. Ando S, Tanaka Y. Synaptic membrane aging in the central nervous system. Gerontology. 1990; 36 Suppl 1: 10-14.
75. Tanaka Y, Ando S. Age-related changes in [3H] ouabain binding to synaptic plasma membranes isolated from mouse brains. J. Biochem. 1992; 112: 117-121.
76. Meier-Ruge W, Iwangoff P, Reichlmeier K, Sadoz P. Neurochemical findings in the aging brain. Adv. Biochem. Psychopharmacol. 1980; 23: 323-338.
77. Harik SI, Mitchell MJ, Kalaria RN. Ouabain Binding in the Human Brain. Arch. Neurol. 1989; 46: 951-954.
78. Kennedy RH, Akera T, Katano Y. Aging: effects on sodium-and potassium-activated adenosine triphosphatase activity and ouabain binding sites in rat brain. J. Gerontol. 1985; 40: 401-408.
79. Fraser CL, Arieff AI. Na-K-ATPase activity decreases with aging in female rat brain synaptosomes Am. J. Physiol. Renal Physiol. 2001; 281: F674-F678.
80. Chakraborty H, Sen P, Sur A, Chatterjee U, Chakrabarti S. Agerelated oxidative inactivation of Na+, K+-ATPase in rat brain crude synaptosomes. Exp. Gerontol. 2003; 38: 705-710.
81. Chauhan NB, Lee JM, Siegel GJ. Na, K-ATPase mRNA levels and plaque load in Alzheimer's disease. J. Mol. Neurosci. 1997; 9: 151-166.
82. Gorini A, Canosi U, Devecchi E, Geroldi D, Villa RF. ATPases enzyme activities during ageing in different types of somatic and synaptic plasma membranes from rat frontal cerebral cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2002; 26: 81-90.
83. Reime Kinjo E, Arida RM, Mara de Oliveira D, da Silva Fernandes MJ. The Na+, K+-ATPase activity is increased in the hippocampus after multiple status epilepticus induced by pilocarpine in developing rats. Brain Res. 2007; 1138: 203-207.
84. Grady CL. Cognitive neuroscience of aging. Ann. N. Y. Acad. Sci. 2008; 1124: 127-144.
85. Singh R, Mishra M, Singh S, Sharma D. Effect of L-deprenyl treatment on electrical activity, Na+, K+-ATPase, and protein kinase C activities in hippocampal subfields (CA1 and CA3) of aged rat brain. Indian J. Exp. Biol. 2012; 50: 101-109.
86. Villa RF, Gorini A, Hoyer S. ATPases of Synaptic Plasma Membranes from Hippocampus after Ischemia and Recovery during Ageing. Neurochem. Res. 2002; 27: 861-870.
87. Leenen FH, Harmsen E, Yu H. Dietary sodium and central vs. peripheral ouabain-like activity in Dahl salt-sensitive vs. salt-resistant rats. Am. J. Physiol. 1994; 267: H1916-H1920.
88. Chow MK, Shao Q, Ren B, Leenen FH, Van Huysse JW. Changes in brain Na, K-ATPase isoform expression and enzymatic activity after aortic constriction. Brain Res. 2002; 944: 124-134.
89. Anner BM, Imesch E, Moosmayer M. Normal sensitivity of Na+, K+-ATPase isolated from brain and kidney of spontaneouly hypertensive rats to sodium, ouabain or mercury. Biochim. Biophys. Acta. 1995; 1270: 95-99.
90. Lees GJ. Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res. Brain Res. Rev. 1991; 16: 283-300.
91. Kempski O. Cerebral edema. Semin. Nephrol. 2001; 21: 303-307.
92. Masocha W, Horvath C, Agil A, Ocana M, Del Pozo E, et al. Role of Na+, K+-ATPase in morphine-induced antinociception. J. Pharmacol. Exp. Ther. 2003; 306: 1122-1128.
93. Mintorovitch J, Yang GY, Shimizu H, Kucharczyk J, Chan PH, et al. Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: comparison of signal intensity with changes in brain water and Na(+), K(+)-ATPase activity. J. Cerebr. Blood Flow Metab. 1994; 14: 332-336.
94. Jamme I, Petit E, Gerbi A., Maixent JM, MacKenzie ET, et al. Changes in ouabain affinity of Na+, K+-ATPase during focal cerebral ischaemia in the mouse. Brain Res. 1997; 774: 123-130.
95. Jamme I, Barbey O, Trouve P, Charlemagne D, Maixent JM, et al. Focal cerebral ischaemia induces a decrease in activity and a shift in ouabain affinity of Na+, K+-ATPase isoforms without modifications in mRNA and protein expression. Brain Res. 1999; 819: 132-142.
96. de Souza Wyse AT, Streck EL, Worm P, Wajner A, Ritter F, et al. Preconditioning prevents the inhibition of Na+, K+-ATPase activity after brain ischemia. Neurochem. Res. 2000; 25: 971-975.
97. Tian D, Dmitrieva RI, Doris PA, Crary JF, Sondhi R, et al. Protein kinase M zeta regulation of Na/K-ATPase: a persistent neuroprotective mechanism of ischemic preconditioning in hippocampal slice cultures. Brain Res. 2008; 1213: 127-139.
98. Lichtstein D, Samuelov S, Bourrit A. Characterization of the stimulation of neuronal Na(+), K(+)-ATPase activty by low concentrations of ouabain. Neurochem. Int. 1985; 7: 709-715.
99. Oselkin M, Tian D, Bergold PJ. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia. Neurosci. Lett. 2010; 473: 67-71.
100. Zhan L, Peng W, Sun W, Xu E. Hypoxic preconditioning induces neuroprotection against transient global ischemia in adult rats via preservation the activity of Na+, K+-ATPase. Neurochem. Int. 2011; 59: 65-72.
101. Silva LF, Hoffmann MS, Rambo LM, Ribeiro LR, Lima FD, et al. The involvement of Na+, K+-ATPase activity and free radical generation in the susceptibility to pentylenetetrazol-induced seizures after experimental traumatic brain injury. J. Neurol. Sci. 2011; 308: 35-40.
102. Mota BC, Pereira L, Souza MA, Silva LF, Magni DV, et al. Exercise pre-conditioning reduces brain inflammation and protects against toxicity induced by traumatic brain injury: behavioral and neurochemical approach. Neurotox. Res. 2012; 21: 175-184.
103. Bagrov AY, Bagrov YY, Fedorova OV, Kashkin VA, Patkina NA, et al. Endogenous digitalis-like ligands of the sodium pump: possible involvement in mood control and ethanol addiction. Eur. Neuropsychopharmacol. 2002; 12: 1-12.
104. Traub N, Lichtstein D. The mood cycle hypothesis: possible involvement of steroid hormones in mood regulation by means of Na+, K+-ATPase inhibition. J. Basic Clin. Physiol. Pharmacol. 2000; 11: 375-394.
105. Kendler KS, Thornton LM, Gardner CO. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am. J. Psychiatry. 2001; 158: 582-586.
106. Naylor GJ, Smith AH, Dick EG, Dick DA, McHarg AM, et al. Erythrocyte membrane cation carrier in manic-depressive psychosis. Psycol. Med. 1980; 10: 521-525.
107. Hokin-Neaverson M, Jefferson JW. Deficient erythrocyte NaKATPase activity in different affective states in bipolar affective disorder and normalization by lithium therapy. Neuropsychobiology. 1989; 22: 18-25.
108. Wood AJ, Smith CE, Clarke EE, Cowen PJ, et al. Altered in vitro adaptive responses of lymphocyte Na(+), K(+)-ATPase in patients with manic depressive psychosis. J. Affect. Disord. 1991; 21: 199-206.
109. Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, et al. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci. Res. 2008; 60: 184-191.
110. Gamaro GD, Streck EL, Matte C, Prediger ME, Wyse AT. Reduction of hippocampal Na+, K+-ATPase activity in rats subjected to an experimental model of depression. Neurochem. Res. 2003; 28: 1339-1344.
111. a. de Vasconcellos AP, Zugno AI, Dos Santos AH, Nietto FB, Crema LM, et al. Na+, K+-ATPase activity is reduced in hippocampus of rats submitted to an experimental model of depression: effect of chronic lithium treatment and possible involvement in learning deficits. Neurobiol. Learn. Mem. 2005; 84: 102-110.
112. Pinacho R, Villalmanzo N, Lalonde J, Haro JM, Meana JJ, et al. The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithium. Bipolar Disord. 2011; 13: 474-485.
113. Kirshenbaum GS, Saltzman K, Rose B, Petersen J, Vilsen B, et al. Decreased neuronal Na+, K+-ATPase activity in Atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress. Genes Brain Behav. 2011; 10: 542-550.
114. Yu JJ, Zhang Y, Wang Y, Wen ZY, Liu XH, et al. Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway. Psychopharmacology (Berl). 2013; 225: 361-372.
115. El-Mallakh RS, El-Masri MA, Huff MO, Li XP, Decker S, et al. Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disord. 2003; 5: 362-365.
116. Kim SH, Yu HS, Park HG, Jeon WJ, Song JY, et al. Dose-dependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1/2-ERK1/2-p90RSK pathway in the rat brain related to locomotor activity. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2008; 32: 1637-1642.
117. Yu HS, Kim SH, Park HG, Kim YS, Ahn YM. Activation of Akt signaling in rat brain by intracerebroventricular injection of ouabain: a rat model for mania. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2010; 34: 888-894.
118. Yu HS, Kim SH, Park HG, Kim YS, Ahn YM. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates tyrosine hydroxylase through extracellular signal-regulated kinase in rat striatum. Neurochem. Int. 2011; 59: 779-786.
119. Hilgenberg LG, Su H, Gu H, O'Dowd DK, Smith MA. Alpha3 Na+/K+-ATPase is a neuronal receptor for agrin. Cell. 2006; 125: 359-369.
120. Kirshenbaum GS, Clapcote SJ, Duffy S, Burgess CR, Petersen J, et al. Mania-like behavior induced by genetic dysfunction of the neuronspecific Na+, K+-ATPase α3 sodium pump. Proc. Natl. Acad. Sci. USA. 2011b; 108: 18144-18149.
121. Kirshenbaum GS, Clapcote SJ, Petersen J, Vilsen B, Ralph MR, et al. Genetic suppression of agrin reduces mania-like behavior in Na+, K+-ATPase alpha3 mutant mice. Genes Brain Behav. 2012; 11: 436-443.
122. Silveira PP, Portella AK, Benetti Cda S, Zugno AI, Scherer EB, et al. Association between Na+, K+-ATPase activity and the vulnerability/resilience to mood disorders induced by early life experience. Neurochem. Res. 2011; 36: 2075-2082.
123. Balk RdeS, Silva MH, Bridi JC, Carvalho NR, Portella RdeL, et al. Effect of repeated restraint stress and clomipramine on Na+/K+-ATPase activity and behavior in rats. Int. J. Dev. Neurosci. 2011; 29: 909-916.
124. Renkawek K, Renier WO, de Pont JJ, Vogels OJ, Gabreels FJ. Neonatal status convulsivus, spongiform encephalopathy, and low activity of Na+, K+-ATPase in the brain. Epilepsia. 1992; 33: 58-64.
125. De Robertis E, Alberici M, Rodríguez de Lores Arnaiz G. Astroglial swelling and phosphohydrolases in cerebral cortex of metrazol convulsant rats. Brain Res. 1969; 12: 461-466.
126. Guillaume D, Grisar T, Delgado-Escueta AV, Bureau-Heeren M, Laschet J. Phosphorylation of brain (Na+, K+)-ATPase alpha catalytic subunits in normal and epileptic cerebral cortex: I. The audiogenic mice and the cat with a freeze lesion. J. Neurosci. Res. 1991; 29: 207-217.
127. Xiong ZQ, Stringer JL. Sodium pump activity, not glial spatial buffering, clears potassium after epileptiform activity induced in the dentate gyrus. J. Neurophysiol. 2000; 83: 1443-1451.
128. Vaillend C, Mason SE, Cuttle MF, Alger BE. Mechanisms of Neuronal Hyperexcitability Caused by Partial Inhibition of Na+-K+-ATPases in the Rat CA1 Hippocampal Region. J. Neurophysiol. 2002; 88: 2963-2978.
129. Tavraz NN, Friedrich T, Dürr KL, Koenderink JB, Bamberg E, et al. Diverse functional consequences of mutations in the Na+/K+-ATPase alpha2-subunit causing familial hemiplegic migraine type 2. J. Biol. Chem. 2008; 283: 31097-31106.
130. Jurkat-Rott K, Freilinger T, Dreier JP, Herzog J, Göbel H, et al. Variability of familial hemiplegic migraine with novel A1A2 Na+, K+-ATPase variants. Neurology. 2004; 62: 1857-1861.
131. Clapcote SJ, Duffy S, Xie G, Kirshenbaum G, Bechard AR, et al. Mutation I810N in the alpha3 isoform of Na+, K+-ATPase causes impairements in the sodium pump and hyperexcitability in the CNS. Proc. Natl. Acad. Sci. USA. 2009; 106: 14085-14090.
132. Thomsen LL, Ostergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology. 2003; 60: 595-601.
133. Gallanti A, Tonelli A, Cardin V, Bussone G, Bresolin N, et al. A novel de novo nonsense mutation in ATP1A2 associated with sporadic hemiplegic migraine and epileptic seizures. J. Neurol. Sci. 2008; 273: 123-126.
134. Bøttger P, Doǧanli C, Lykke-Hartmann K. Migraine-and dystoniarelated disease-mutations of Na+/K+-ATPases: relevance of behavioral studies in mice to disease symptoms and neurological manifestations in humans. Neurosci. Biobehav. Rev. 2012; 36: 855-871.
135. Khan FH, Sen T, Chakrabarti S. Dopamine oxidation products inhibit Na+, K+-ATPase activity in crude synaptosomal-mitochondrial fraction from rat brain. Free Radic. Res. 2003; 37: 597-601.
136. Aperia A. new roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target. J. Intern. Med. 2007; 261: 44-52.
137. Kim SH, Yu HS, Park HG, Ha K, Kim YS, et al. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2013; 45C: 73-82.
138. Silva LF, Hoffmann MS, Gerbatin Rda R, Fiorin Fda S, Dobrachinski F, et al. Treadmill exercise protects against pentylenetetrazol-induced seizures and oxidative stress after traumatic brain injury. J. Neurotrauma. 2013; 30: 1278-1287.
139. Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009; 118: 5-36.
140. Wong PC, Savonenko A, Li T, Price DL. Neurobiology of Alzheimer's Disease. In: Brady ST, Siegel GJ, Albers RW, Price D (Eds.), Basic Neurochemistry: Principles of Molecular, Cellular and Medical Neurobiology, 8th edn. Massachusetts, USA: Elsevier Academic Press. 2012; 815-828.
141. Liguri G, Taddei N, Nassi P, Latorraca S, Neidiani C, et al. Changes in Na+, K+-ATPase, Ca2+-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease. Neurosci. Lett. 1990; 112: 338-342.
142. Marck RJ, Hensley K, Butterfield DA, Mattson MP. Amyloid betapeptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. J. Neurosci. 1995; 15: 6239-6249.
143. Marck RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. Amyloid beta-peptide impairs glucose transport in hippocampaland cortical neurons: Involvement of membrane lipid peroxidation. J. Neurosci. 1997b; 17: 1046-1054.
144. Marck RJ, Keller JN, Kruman I, Mattson MP. Basic FGF attenuates beta-peptide-induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+-ATPase activity hippocampal neurons. Brain Res. 1997; 756: 205-214.
145. Bores GM, Smith CP, Wirtz-Brugger F, Giovanni A. Amyloid betapeptides inhibit Na+, K+-ATPase: tissue slices versus primary cultures. Brain Res. Bull. 1998; 46: 423-427.
146. Hattori N, Kitagawa K, Higashida T, Yagyu K, Shimohama S, et al. Cl--ATPase and Na+, K+-ATPase activities in Alzheimer's disease brains. Neurosci. Letters. 1998; 254: 141-144.
147. Braithwaite SP, Stock JB, Lombroso PJ, Nairn AC. Protein phosphatases and Alzheimer's disease. Prog. Mol. Biol. Transl. Sci. 2012; 106: 343-379.
148. Karch CM, Jeng AT, Goate AM. Calcium phosphatase calcineurin influences tau metabolism. Neurobiol. Aging. 2013; 34: 374-386.
149. Wu HY, Hudry E, Hashimoto T, Kuchibhotla K, Rozkaine A, et al. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J. Neurosci. 2010; 30: 2636-2649.
150. Benilova I, Karran E, De Strooper B. The toxic A β oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci. 2012; 15: 349-357.
151. Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer Aβ oligomer bound to cellular prion protein. Neuron. 2013; 79: 887-902.
152. Jo J, Whicomb DJ, Olsen KM, Kerrigan TL, Lo SC, et al. Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat. Neurosci. 2011; 14: 545-547.
153. Deng Y, Xiong Z, Chen P, Wei J, Chen S, et al. β-Amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3. Neurobiol. Aging. 2013 [Epub ahead].
154. Wang ZC, Zhao J, Li S. Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β. Neurosci. Bull. 2013; oct 17 [Epub ahead of print].
155. Rodríguez de Lores Arnaiz G. Interplay between Na+, K+-ATPase and neurotransmitter receptors. In: Richard R. (Ed.). Current Topics in Neurochemistry, Vol. 3, Trivandrum, India: Research Trends. 2002; p189-198.
156. Bersier MG, Peña C, Rodríguez de Lores Arnaiz G. The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor. Neurochem. Res. 2008; 33: 66-72.
157. Bersier MG, Rodríguez de Lores Arnaiz G. Intracerebroventricular administration of ouabain to rats changes the expression of NMDA receptor subunits in cerebral cortex and hippocampus. Neurochem. Res. 2009; 34: 1650-1657.
158. Unoki T, Matsuda S, Kakegawa W, Van NT, Kohda K, et al. NMDA receptor-mediated PIP5K activation to produce PI(4, 5)P2 is essential for AMPA receptor endocytosis during LTD. Neuron. 2012; 73: 135-148.
159. Sato T, Tanaka K, Ohnishi Y, Teramoto T, Irifune M, et al. Effects of steroid hormones on (Na+, K+)-ATPase activity inhibition-induced amnesia on the step-through passive avoidance task in gonadectomized mice. Pharmacol. Res. 2004; 49: 151-159.
160. Stevens MJ, Dananberg J, Feldman EL, Lattimer SA, Kamijo M, et al. The linked roles of nitric oxide, aldose reductase and (Na+-K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J. Clin. Invest. 1994; 94: 853-859.
161. Garvryck WA, Moore RD, Thompson RC. Effect of insulin upon membrane-bound (Na+/K+-ATPase)-ATPase extracted from skeletal muscle. J. Physiol. 1975; 252: 43-58.
162. Bojorge G, Rodríguez de Lores Arnaiz G. Insulin modifies Na+, K+-ATPase activity of synaptosomal membranes and whole homogenates prepared from rat cerebral cortex. Neurochem. Int. 1987; 11: 11-16.
163. Brodsky JL. Insulin activation of brain Na(+) + K(+) ATPase is medi ated by alpha 2-isoform of enzyme. American J. Physiol. 1990; 258 Issue 5 Pt. 1, C812-C817.
164. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 2001; 50: 537-546.
165. Vér A, Csermely P, Bányász T, Kovács T, Somogyi J. Alterations in the properties and isoform ratios of brain Na+/K+-ATPase in streptozotocin diabetic rats. Biochim. Biophys. Acta. 1995; 1237: 143-150.
166. Michea L, Irribarra V, Goecke IA, Marusic ET. Reduced Na-K pump but increased Na-K-2Cl cotransporter in aorta of streptozotocin-induced diabetic rat. Am. J. Physiol. Heart Circ. Physiol. 2001; 280: H851-H858.
167. Zarros A, Liapi C, Galanopoulou P, Marinou K, Mellios Z, et al. Effects of adult-onset streptpzotocin-induced diabetes on the rat brain antioxidant status and the activities of acetylcholinesterase, Na(+), K(+)-and Mg(2+)-ATPase: modulation by cysteine. Metab. Brain Dis. 2009; 24: 337-348.
168. López Ordieres MG, Rosin C, Miño J, Rodríguez de Lores Arnaiz G. Na+, K+-ATPase response to neurotensin is altered by streptozotocin administration. Current Topics in Peptide & Protein Research. 2013 (in press).
169. Lefranc F, Mijatovic T, Kiss R. The sodium pump could constitute a new target to combat gliobastomas. Bull. Cancer. 2008; 95: 271-281.
170. Lefranc F, Kiss R. The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant gliobastomas. Neoplasia. 2008; 10: 198-206.
171. Wang MW, Gu P, Zhang ZL, Zhu ZL, Geng Y, et al. FXYD3 expression in gliomas and its clinicopathological significance. Oncol. Res. 2009; 18: 133-139.
172. Rodríguez de Lores Arnaiz G, De Robertis E. Properties of the isolated nerve endings. In: Bronner F, Kleinzeller A (Eds.) Current Topics in Membranes and Transport, Vol. III. Nueva York, USA: Academic Press. 1972; p237-272.
173. Zhang NY, Sillar KT. Short-term memory of network performance via activity-dependent potentiation of Na+/K+ pump function. Curr. Biol. 2013; 22: 526-531.
174. Lundborg C, Westerlund A, Björklund U, Biber B, Hansson E. Ifenprodil restores GDNF-evoked Ca(2+) signaling and Na(+)/K(+)-ATPase expression in inflammation-pretreated astrocytes. J. Neurochem. 2011; 119: 6 86-696.
175. Boutillier S, Lannes B, Buée L, Delacourte A, Rouaux C, et al. Sp3 and Sp4 transcription factor levels are increased in brains of patients with Alzheimer disease. Neurodegener. Dis. 2007; 4: 413-423.